Category
News
ISPE Annual Meeting 2024
bluebird bio
Gene therapy facility
Location
United States
Key Statistics
- Client
- bluebird bio
- PM Group Office
- Boston
- Cost
- Confidential
- Size
- 53,000 sq.ft.
bluebird bio is a clinical-stage company that develops potentially transformative therapies with product platforms including gene therapy, cancer immunotherapy and gene editing. PM Group has worked with bluebird bio since 2015, providing high level Subject Matter Expert (SME) support, as well as engineering design services.
Do you have a pharmaceutical project? Talk to one of our experts.
Andy Rayner
Pharmaceutical Sector Director
Viral vector manufacturing facility
PM Group designed a 53,000 sq.ft. world-class viral vector manufacturing facility in Durham, NC. The project had a fast track schedule with 16 months from construction commencement to manufacturing start. Our team provided process engineering design including P&IDs, equipment specification, procurement support, process simulation and modeling for production planning.
1st
Gene therapy facility in the USA
53,000
sq.ft. world-class viral vector manufacturing facility
16 mth
from construction start to manufacturing start-up
Technologies on this Project include:
- Single use technologies (bioreactors and purification) for viral vector preparation
- Filling line and isolator
- BSL-2 level of containment